Shanghai Shen Lian Biomedical Corporation (SHA:688098)

Market Cap	3.56B -20.2%
Revenue (ttm)	278.46M -6.8%
Net Income	-26.77M
EPS	-0.07
Shares Out	410.64M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,985,697
Open	8.82
Previous Close	8.82
Day's Range	8.67 - 8.91
52-Week Range	7.29 - 12.36
Beta	0.54
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 31, 2026

About SHA:688098

Shanghai Shen Lian Biomedical Corporation engages in the research, development, production, and sale of veterinary biological products in China. The company offers swine vaccines, ruminant vaccine, diagnostic reagents, and pet biological products. It also provides monoclonal antibody drug for HIV treatment, anti-allergy anti-IgE monoclonal antibody drug, and anti-herpes simplex virus monoclonal antibody drugs. In addition, the company offers foot-and-mouth disease vaccines for pigs, cattle, and sheep; and porcine circovirus type 2 subunit vacci...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Employees: 376
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688098

Financial Performance

In 2025, SHA:688098's revenue was 288.27 million, a decrease of -4.99% compared to the previous year's 303.41 million. Losses were -20.50 million, -54.19% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 23, 2026

Data Sources Report a data error